Drugs / UT-231B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00069511 | Jul 2003 → Dec 2004 | hepatitis C virus infection | United Therapeutics | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UT-231B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00069511 ↗ |
| Modality | Small molecule | — CHEMBL4300049 ↗ |
| Route | Oral | “Oral UT-231B” NCT00069511 ↗ |